← Leaderboards
M. Reza Ghadiri
Scripps Research Institute
$31,671,442
Attributed
$31,671,442
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,671,442 · 8
By mechanism
R01$31,149,217 · 7
R21$522,225 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- J. Lindsay Whitton$31,825,279
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPreventBaseLeadProgramsIn VitroPeptidesIn VivoLipidsAmino AcidsCyclic PeptidesNovel TherapeuticsMolecularAtherosclerosisPlasmaCholesterolProteinsSeriesStructureTherapeutic AgentsOralBiologicalProductionCost
Grant awards (50)
Managing Atherosclerosis by Modulating HDL Function$773,645
R01 · FY2025 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$758,172
R01 · FY2024 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$773,645
R01 · FY2023 · HL · contact PI
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis$748,564
R01 · FY2023 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$779,185
R01 · FY2022 · HL · contact PI
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis$734,089
R01 · FY2022 · HL · contact PI
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis$734,089
R01 · FY2021 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$693,767
R01 · FY2021 · HL · contact PI
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis$734,089
R01 · FY2020 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$693,767
R01 · FY2020 · HL · contact PI
Managing Atherosclerosis by Modulating HDL Function$693,767
R01 · FY2019 · HL · contact PI
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics$384,239
R01 · FY2019 · GM · contact PI
Managing Atherosclerosis by Modulating HDL Function$729,767
R01 · FY2018 · HL · contact PI
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics$384,239
R01 · FY2018 · GM · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,025,613
R01 · FY2017 · HG · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,025,613
R01 · FY2016 · HG · contact PI
Managing Atherosclerosis by Modulating HDL Function$673,750
R01 · FY2016 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,038,264
R01 · FY2015 · HG · contact PI
Managing Atherosclerosis by Modulating HDL Function$653,301
R01 · FY2015 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,093,860
R01 · FY2014 · HG · contact PI
Managing Atherosclerosis by Modulating HDL Function$649,985
R01 · FY2014 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,144,742
R01 · FY2013 · HG · contact PI
Managing Atherosclerosis by Modulating HDL Function$631,414
R01 · FY2013 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,198,680
R01 · FY2012 · HG · contact PI
Synthesis and Application of Novel Apolipoprotein Mimetics$189,900
R21 · FY2012 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,198,680
R01 · FY2011 · HG · contact PI
Synthesis and Application of Novel Apolipoprotein Mimetics$332,325
R21 · FY2011 · HL · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$1,426,098
R01 · FY2010 · HG · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$832,531
R01 · FY2009 · HG · contact PI
Organic Nanotubes Design and Biological Applications$414,010
R01 · FY2009 · GM · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$810,135
R01 · FY2008 · HG · contact PI
Organic Nanotubes Design and Biological Applications$414,010
R01 · FY2008 · GM · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$793,957
R01 · FY2007 · HG · contact PI
Organic Nanotubes Design and Biological Applications$406,145
R01 · FY2007 · GM · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$795,757
R01 · FY2006 · HG · contact PI
Organic Nanotubes Design and Biological Applications$418,275
R01 · FY2006 · GM · contact PI
Design of Intrasterically Regulated Chimeric Enzymes$325,847
R01 · FY2006 · GM · contact PI
Single-Molecule DNA Sequencing with Engineered Nanopores$790,094
R01 · FY2005 · HG
Organic Nanotubes Design and Biological Application$383,364
R01 · FY2005 · GM
Design of Intrasterically Regulated Chimeric Enzymes$333,689
R01 · FY2005 · GM
Organic Nanotubes Design and Biological Application$383,364
R01 · FY2004 · GM
Design of Intrasterically Regulated Chimeric Enzymes$333,689
R01 · FY2004 · GM
Organic Nanotubes Design and Biological Application$386,768
R01 · FY2003 · GM
Design of Intrasterically Regulated Chimeric Enzymes$355,911
R01 · FY2003 · GM
Organic Nanotubes Design and Biological Application$386,768
R01 · FY2002 · GM
DE NOVO DESIGN OF PEPTIDE CATALYSTS$100,930
R01 · FY2002 · GM
DE NOVO DESIGN OF PEPTIDE CATALYSTS$280,149
R01 · FY2001 · GM
ORGANIC NANOTUBES DESIGN AND BIOLOGICAL APPLICATIONS$278,920
R01 · FY2001 · GM
DE NOVO DESIGN OF PEPTIDE CATALYSTS$275,769
R01 · FY2000 · GM
ORGANIC NANOTUBES DESIGN AND BIOLOGICAL APPLICATIONS$274,111
R01 · FY2000 · GM